6.
Manrai A, Cui Y, Bushel P, Hall M, Karakitsios S, Mattingly C
. Informatics and Data Analytics to Support Exposome-Based Discovery for Public Health. Annu Rev Public Health. 2017; 38:279-294.
PMC: 5774331.
DOI: 10.1146/annurev-publhealth-082516-012737.
View
7.
Selmi C, Leung P, Sherr D, Diaz M, Nyland J, Monestier M
. Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun. 2012; 39(4):272-84.
DOI: 10.1016/j.jaut.2012.05.007.
View
8.
Dou D, Zhao Y, Belk J, Zhao Y, Casey K, Chen D
. Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell. 2024; 187(3):733-749.e16.
PMC: 10949934.
DOI: 10.1016/j.cell.2023.12.037.
View
9.
Whitacre C
. Sex differences in autoimmune disease. Nat Immunol. 2001; 2(9):777-80.
DOI: 10.1038/ni0901-777.
View
10.
Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J
. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349(16):1526-33.
DOI: 10.1056/NEJMoa021933.
View
11.
Wood R, Guthridge L, Thurmond E, Guthridge C, Kheir J, Bourn R
. Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus. J Transl Autoimmun. 2022; 4():100117.
PMC: 8716608.
DOI: 10.1016/j.jtauto.2021.100117.
View
12.
Ronsmans S, Hougaard K, Nawrot T, Plusquin M, Huaux F, Cruz M
. The EXIMIOUS project-Mapping exposure-induced immune effects: connecting the exposome and the immunome. Environ Epidemiol. 2022; 6(1):e193.
PMC: 8835560.
DOI: 10.1097/EE9.0000000000000193.
View
13.
Miller F, Alfredsson L, Costenbader K, Kamen D, Nelson L, Norris J
. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012; 39(4):259-71.
PMC: 3496812.
DOI: 10.1016/j.jaut.2012.05.002.
View
14.
Conrad N, Misra S, Verbakel J, Verbeke G, Molenberghs G, Taylor P
. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023; 401(10391):1878-1890.
DOI: 10.1016/S0140-6736(23)00457-9.
View
15.
Maitre L, Bustamante M, Hernandez-Ferrer C, Thiel D, Lau C, Siskos A
. Multi-omics signatures of the human early life exposome. Nat Commun. 2022; 13(1):7024.
PMC: 9678903.
DOI: 10.1038/s41467-022-34422-2.
View
16.
Parks C, Miller F, Pollard K, Selmi C, Germolec D, Joyce K
. Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease. Int J Mol Sci. 2014; 15(8):14269-97.
PMC: 4159850.
DOI: 10.3390/ijms150814269.
View
17.
Cooper G, Gilbert K, Greidinger E, James J, Pfau J, Reinlib L
. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Cien Saude Colet. 2009; 14(5):1865-76.
DOI: 10.1590/s1413-81232009000500028.
View
18.
Shanmugam V, Clayton J
. Introducing the Office of Autoimmune Disease Research. Arthritis Rheumatol. 2024; 76(8):1214-1217.
DOI: 10.1002/art.42837.
View
19.
Fechtner S, Berens H, Bemis E, Johnson R, Guthridge C, Carlson N
. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles. Arthritis Rheumatol. 2021; 74(4):597-603.
PMC: 8957485.
DOI: 10.1002/art.41994.
View
20.
Leffers H, Lange T, Collins C, Ulff-Moller C, Jacobsen S
. The study of interactions between genome and exposome in the development of systemic lupus erythematosus. Autoimmun Rev. 2019; 18(4):382-392.
DOI: 10.1016/j.autrev.2018.11.005.
View